Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Cardiovascular Diseases

medtech-news-updates-for-renew-bioscience-perimeter-medical-smithnephew-perimeter-medical-imaging-ai-saga-diagnostics-astrazeneca-magnus-medical-revalve-solutions

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Smith+Nephew’s LEGION CONCELOC; Renew Bioscience’s Cerezen; Perimeter Medical’s ATLAS AI Project; SAGA Diagnostics-AZ’s Deal; Magnus Receives Breakthrough Device Designation; ReValve’s Transeptal Mitral Valve Replacement

ReValve Solutions, Inc. declares successful first human use of the Transeptal Mitral Valve Replacement On November 01, 2021, ReValve Solutions, Inc., a company operating in the field of transcatheter structural heart replacement and repair, announced the successful first human use of its transcatheter, Palmetto System, for mitral valve replacement. It treated the patient successfully who suffered from severe mitral valve regurgitation and heart failure. Dr Charles Davidson (Medical Director, Bluhm Cardiovascular Institute) and Dr Edris Aman (Assistant Clinical Professor of Cardiovascular Medicine at the University of California, Davis Medicine Center spec...

Explore More...

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Cardiovascular Diseases

Smith+Nephew’s LEGION CONCELOC; Renew Bioscience’s Cerezen; Perimeter Medical’s ATLAS AI Project; SAGA Diagnostics-AZ’s Deal; Magnus Receives Breakthrough Device Designation; ReValve’s Transeptal Mitral Valve Replacement

Sorry no data found.

More Views & Analysis

Sorry no data found.

Subscribe to our Updates

Daily

Weekly

Monthly